Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca announces sale of Alderley Park site in Cheshire, UK
-
AstraZeneca and Korea Health Industry Development Institute to establish oncology research programme
-
US FDA approves Bydureon® Pen (exenatide extended-release for injectable suspension) for once-weekly treatment of adults with type 2 diabetes
-
US FDA approves orphan drug MYALEPT™ (metreleptin for injection)
-
AstraZeneca scientists to work alongside researchers at Cancer Research UK Cambridge Institute
-
AstraZeneca PLC fourth quarter and full year results 2013
-
AstraZeneca completes the acquisition of Bristol-Myers Squibb share of global diabetes alliance
-
AstraZeneca and Shanghai Institutes of Biological Sciences announce research collaboration
-
XIGDUO™ (dapagliflozin and metformin hydrochloride) approved in the European Union for type 2 diabetes
-
AstraZeneca provides update at JP Morgan Healthcare Conference on progress to achieve scientific leadership and return to growth
Latest articles and press releases
All of our latest press releases and articles are available to explore
